A detailed history of Harrell Investment Partners, LLC transactions in Eli Lilly & CO stock. As of the latest transaction made, Harrell Investment Partners, LLC holds 461 shares of LLY stock, worth $421,616. This represents 0.11% of its overall portfolio holdings.

Number of Shares
461
Previous 454 1.54%
Holding current value
$421,616
Previous $264 Million 35.54%
% of portfolio
0.11%
Previous 0.08%

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

May 10, 2024

BUY
$592.2 - $792.28 $4,145 - $5,545
7 Added 1.54%
461 $358 Million
Q3 2023

Oct 30, 2023

BUY
$434.7 - $599.3 $434 - $599
1 Added 0.22%
454 $244 Million
Q2 2023

Aug 08, 2023

BUY
$350.74 - $468.98 $158,885 - $212,447
453 New
453 $213 Million

Others Institutions Holding LLY

About ELI LILLY & Co


  • Ticker LLY
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 950,174,976
  • Market Cap $869B
  • Description
  • Eli Lilly and Company discovers, develops, and markets human pharmaceuticals worldwide. It offers Basaglar, Humalog, Humalog Mix 75/25, Humalog U-100, Humalog U-200, Humalog Mix 50/50, insulin lispro, insulin lispro protamine, insulin lispro mix 75/25, Humulin, Humulin 70/30, Humulin N, Humulin R, and Humulin U-500 for diabetes; and Jardiance, T...
More about LLY
Track This Portfolio

Track Harrell Investment Partners, LLC Portfolio

Follow Harrell Investment Partners, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Harrell Investment Partners, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Harrell Investment Partners, LLC with notifications on news.